Home Cart Sign in  
Chemical Structure| 32986-56-4 Chemical Structure| 32986-56-4

Structure of Tobramycin
CAS No.: 32986-56-4

Chemical Structure| 32986-56-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Tobramycin is an aminoglycoside, broad-spectrum antibiotic produced by Streptomyces tenebrarius.

Synonyms: Nebramycin Factor 6; Deoxykanamycin B; NSC 180514

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Tobramycin

CAS No. :32986-56-4
Formula : C18H37N5O9
M.W : 467.51
SMILES Code : O[C@@H]([C@@H]1O[C@@]([C@@H](C[C@@H]2O)N)([H])O[C@@H]2CN)[C@H]([C@@H](C[C@@H]1N)N)O[C@@]([C@@H]([C@@H](N)[C@@H]3O)O)([H])O[C@@H]3CO
Synonyms :
Nebramycin Factor 6; Deoxykanamycin B; NSC 180514
MDL No. :MFCD00077885
InChI Key :NLVFBUXFDBBNBW-PBSUHMDJSA-N
Pubchem ID :36294

Safety of Tobramycin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02958514 Dry Eye Syndrome Not Applicable Unknown March 2017 -
NCT01319253 - Completed - United States, Indiana ... More >> Indiana University Indianapolis, Indiana, United States, 46202 Less <<
NCT02334384 Furunculosis Phase 1 Phase 2 Completed - United States, Virginia ... More >> Sentara Norfolk General Hospital Norfolk, Virginia, United States, 23507 Less <<
NCT02389036 Critical Illness ... More >> Sepsis Septic Shock Ventilator Associated Pneumonia Less << Phase 3 Recruiting December 2020 Australia, New South Wales ... More >> The George Institute for Global Health Recruiting Sydney, New South Wales, Australia, 2000 Contact: John Myburgh, | MBBCh PhD    61 2 8052 4348    jmyburgh@georgeinstitute.org.au Less <<
NCT02334384 - Completed - -
NCT02526004 Cystic Fibrosis Not Applicable Unknown October 2016 Ireland ... More >> University College Cork Recruiting Cork, Ireland Contact: Barry P Plant, MD          Principal Investigator: Marcus Mall, MD          Principal Investigator: Isabelle Fajac, MD          Principal Investigator: Stuart Elborn, MD          Principal Investigator: Charles Haworth, MD          Principal Investigator: Christopher Goss, MD          Principal Investigator: Lieven Dupont, MD Less <<
NCT01570192 Bacterial Pneumonia Phase 2 Terminated(NIAID terminated th... More >>e study due to low subject enrollment) Less << - United States, California ... More >> InClin, Inc. San Mateo, California, United States, 94403 United States, Florida UFL Department of Medicine: Pulmonary, Critical Care and Sleep Medicine Gainesville, Florida, United States, 32610 United States, Georgia Emory University Atlanta, Georgia, United States, 30322-4250 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Iowa JMI Laboratories North Liberty, Iowa, United States, 52317 United States, Missouri Washington University in St. Louis School of Medicine Saint Louis, Missouri, United States, 63130 United States, New York Weill Cornell Medical Center of Cornell University New York, New York, United States, 10065 United States, Ohio Cleveland Clinic Lerner College of Medicine Cleveland, Ohio, United States, 44195 France Institut de Cardiologie, Groupe Hospitalier Pitie-Salpetriere Paris, France, Cedex 13 Germany Hannover Clinical Trial Center GmbH Hannover, Germany, 30625 Spain Hospital Vall d'Hebron Barcelona, Spain, 08035 Less <<
NCT00532961 Inflammation Phase 4 Completed - -
NCT01044719 Cystic Fibrosis Phase 4 Unknown April 2011 United Kingdom ... More >> Department of Cystic Fibrosis, Royal Brompton Hospital Recruiting London, United Kingdom, Sw3 6NP Less <<
NCT00404937 Post-surgical Inflammation Phase 3 Withdrawn - -
NCT01740947 Colorectal Cancer Phase 4 Terminated(Superiority was no ... More >>longer attainable) Less << - Netherlands ... More >> Slotervaart Ziekenhuis Amsterdam, Netherlands VU University Medical Center Amsterdam, Netherlands Kennemer Gasthuis Haarlem, Netherlands Spaarne Ziekenhuis Hoofddorp, Netherlands WestFries Gasthuis Hoorn, Netherlands Less <<
NCT01460849 - Active, not recruiting - -
NCT02819856 Ototoxicity Phase 1 Phase 2 Enrolling by invitation September 2019 United States, South Carolina ... More >> Medical University of South Carolina Charleston, South Carolina, United States, 29425 Less <<
NCT00097773 - Completed - -
NCT03705962 Fractures, Open Phase 3 Recruiting July 2020 United States, Virginia ... More >> University of Virginia Medical Center Recruiting Charlottesville, Virginia, United States, 22908 Less <<
NCT01570192 - Terminated(NIAID terminated th... More >>e study due to low subject enrollment) Less << - -
NCT01775137 Long-term Safety of TIP Phase 4 Completed - United States, Ohio ... More >> Novartis Investigative Site Akron, Ohio, United States, 44308 United States, South Carolina Novartis Investigative Site Charleston, South Carolina, United States, 29425 United States, Texas Novartis Investigative Site Dallas, Texas, United States, 75230 Novartis Investigative Site Houston, Texas, United States, 77030 Argentina Novartis Investigative Site Caba, Buenos Aires, Argentina, C1425DTG Novartis Investigative Site Capital Federal, Buenos Aires, Argentina, C1425EFD Novartis Investigative Site Córdoba, Cordoba, Argentina, X5014AKN Australia, New South Wales Novartis Investigative Site New Lambton Heights, New South Wales, Australia, 2305 Australia, Victoria Novartis Investigative Site Parkville, Victoria, Australia, 3052 Canada, Quebec Novartis Investigative Site Montreal, Quebec, Canada, H3T1C5 Germany Novartis Investigative Site Essen, Germany, 45147 Hungary Novartis Investigative Site Budapest, Hungary, 1121 Italy Novartis Investigative Site Firenze, FI, Italy, 50139 Novartis Investigative Site Messina, ME, Italy, 98125 Novartis Investigative Site Verona, VR, Italy, 37126 Novartis Investigative Site Palermo, Italy, 90100 Novartis Investigative Site Roma, Italy, 00161 Mexico Novartis Investigative Site Mexico, Distrito Federal, Mexico, 06720 Novartis Investigative Site Monterrey, Nuevo León, Mexico, 64020 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Valencia, Comunidad Valenciana, Spain, 46026 Less <<
NCT02497365 Bacterial Keratitis Not Applicable Unknown July 2017 Canada, Quebec ... More >> McGill Academic Eye Center Recruiting Montreal, Quebec, Canada, H4A 3S9 Contact: Michael Ross, MD    51493444074    mrosscan@gmail.com Less <<
NCT00097773 Cystic Fibrosis ... More >> Pulmonary Disease, Chronic Obstructive Less << Phase 2 Completed - -
NCT01775137 - Completed - -
NCT01456780 Meibomian Gland Dysfunction ... More >> Posterior Blepharitis Less << Phase 4 Completed - United States, Massachusetts ... More >> Massachusetts Eye & Ear Infirmary Boston, Massachusetts, United States, 02114 Less <<
NCT01641822 - Completed - -
NCT02054156 Cystic Fibrosis Phase 3 Completed - -
NCT01456780 - Completed - -
NCT01641822 Cystic Fibrosis Phase 3 Completed - -
NCT02137161 Cataract Pseu... More >>doexfoliation Syndrome Less << Phase 4 Completed - Italy ... More >> Arcispedale Santa Maria Nuova IRCSS - Ophthalmology Reggio Emilia, RE, Italy, 42123 Less <<
NCT01116089 Cystic Fibrosis Phase 1 Completed - Czech Republic ... More >> University Hospital Brno Bohunice Brno, Czech Republic, 625 00 Moldova, Republic of SMSI Institude of Cardiology Chisinau, Moldova, Republic of, MD-2025 Slovakia University hospital with Health Center Banská Bystrica, Slovakia, 975 17 Fakultná nemocnica s poliklinikou Bratislava (FNsP) Brastislava, Slovakia, 826 06 University Hospital of L. Pasteur, Pneumonology Department Kosice, Slovakia, 041 90 Less <<
NCT00357773 Conjunctivitis, Bacterial Phase 3 Completed - -
NCT01315678 Pseudomonas Aeruginosa Infecti... More >>on Less << Phase 3 Completed - -
NCT02918409 Cystic Fibrosis Phase 4 Recruiting January 2021 United States, Colorado ... More >> National Jewish Health Recruiting Denver, Colorado, United States, 80206 Contact: Katie Poch, BS       pochk@njhealth.org    Principal Investigator: Milene Saavedra, MD          Sub-Investigator: Jerry Nick, MD Less <<
NCT00447577 Blepharokeratoconjunctivitis Phase 4 Completed - United States, North Carolina ... More >> Cornerstone Eye Care High Point, North Carolina, United States, 27262 Less <<
NCT01230593 Chalazion Unspecified Eye, Uns... More >>pecified Eyelid Chalazion Left Eye, Unspecified Eyelid Chalazion Right Eye, Unspecified Eyelid Chalazion Both Eyes Less << Not Applicable Completed - United States, New York ... More >> Elmhurst Hospital Center Elmhurst, New York, United States, 11373 Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 Canada, Ontario St. Joseph's Hospital Eye Clinic Stoney Creek, Ontario, Canada, L8G 5E4 Less <<
NCT02248922 Chronic Lung Infection With Ps... More >>eudomonas Aeruginosa in Cystic Fibrosis Less << Phase 4 Terminated(Reason for terminat... More >>ion was challenge with enrollment and recruitment. A significant decrease in the eligible patient population was main driver.) Less << - Germany ... More >> Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Erlangen, Germany, 91054 Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Frankfurt, Germany, 60590 Novartis Investigative Site Germering, Germany, 82110 Novartis Investigative Site Jena, Germany, 07740 Less <<
NCT02248922 - Terminated(Reason for terminat... More >>ion was challenge with enrollment and recruitment. A significant decrease in the eligible patient population was main driver.) Less << - -
NCT00547053 Cystic Fibrosis Phase 1 Completed - United States, Massachusetts ... More >> Children's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT01079559 Infection Ost... More >>eoarthritis of the Knee Less << Phase 3 Withdrawn - Canada, Ontario ... More >> London Health Sciences Centre, University Hospital London, Ontario, Canada, N6A 5W9 Less <<
NCT01155999 Purulent Bacterial Conjunctivi... More >>tis Less << Phase 3 Completed - France ... More >> Clermont-Ferrand, France, 63000 Less <<
NCT01230593 - Completed - -
NCT01155999 - Completed - -
NCT03464435 Vernal Keratoconjunctivitis Phase 4 Completed - -
NCT00420628 Chalazion Hor... More >>deolum Less << Phase 4 Completed - United States, Pennsylvania ... More >> Pediatric Ophthalmology of Erie Erie, Pennsylvania, United States, 16501 Less <<
NCT01749644 - Unknown January 2015 Israel ... More >> Safra Children's Hospital, Sheba Medical Center Not yet recruiting Ramat Gan, Israel Contact: Ifat Sarouk, MD    97235302884 Less <<
NCT01227915 Acute Bacterial Conjunctivitis Phase 3 Unknown - Brazil ... More >> LAL Clínica Pesquisa e Desenvolvimento Ltda Not yet recruiting Valinhos, São Paulo, Brazil Contact: Alexandre Frederico, doctor    55 19 3871-6399    alexandre@lalclinica.com.br    Principal Investigator: Jose Roberto de Camargo, doctor Less <<
NCT02489955 Cystic Fibrosis Not Applicable Unknown - United Kingdom ... More >> Leeds Teaching Hospitals NHS Trust Recruiting Leeds, United Kingdom Contact: Giles Fitch       giles.fitch@nhs.net Less <<
NCT00004829 Cystic Fibrosis ... More >> Bacterial Infection Less << Phase 3 Completed - -
NCT02478710 Pneumonia, Ventilator-Associat... More >>ed Less << Phase 4 Unknown December 2017 United States, Ohio ... More >> Miami Valley Hospital Recruiting Dayton, Ohio, United States, 45409 Contact: Linda Clark, MSN    937-208-2913 Less <<
NCT02734459 Bilateral Cataract Phase 3 Completed - -
NCT01844778 Cystic Fibrosis Phase 4 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site München, Germany, 81241 Novartis Investigative Site Tübingen, Germany, 72076 Ireland Novartis Investigative Site Galway, Ireland Spain Novartis Investigative Site Sevilla, Andalucia, Spain, 41013 Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Valencia, Comunidad Valenciana, Spain, 46026 Novartis Investigative Site Palma De Mallorca, Islas Baleares, Spain, 07120 Novartis Investigative Site Madrid, Spain, 28046 Switzerland Novartis Investigative Site Basel, Switzerland, 4031 Novartis Investigative Site St. Gallen, Switzerland, 9007 Novartis Investigative Site Zürich, Switzerland, 8032 United Kingdom Novartis Investigative Site Southampton, Hampshire, United Kingdom, SO16 6YD Novartis Investigative Site Penarth, Vale of Glamorgan, United Kingdom, CF64 2XX Novartis Investigative Site Birmingham, West Midlands, United Kingdom, b9 5ss Novartis Investigative Site Bristol, United Kingdom, BS1 3NU Novartis Investigative Site East Yorkshire, United Kingdom, HU16 5JQ Novartis Investigative Site Exeter, United Kingdom, EX2 5DW Novartis Investigative Site Liverpool, United Kingdom, L14 3PE Novartis Investigative Site Newcastle upon Tyne, United Kingdom, NE1 4LP Less <<
NCT00420628 - Completed - -
NCT02038803 - Unknown - United States, Illinois ... More >> Rush University Medical Center Recruiting Chicago, Illinois, United States, 60612 Contact: Robert A Balk, MD    (312) 942-6744    robert_a_balk@rush.edu    Contact: Ellen A Becker, PhD, RRT-NPS    (312) 942-5000    ellen_becker@rush.edu    Principal Investigator: Robert A Balk, MD          Sub-Investigator: Roisin McLaughlin, RRT, RPFT          Principal Investigator: Ellen A Becker, PhD,RRT-NPS,RPFT,AE-C, FAARC Less <<
NCT02269969 Burns|Infection PHASE1|PHASE2 COMPLETED 2025-12-15 Sunnybrook Health Sciences Cen... More >>tre, Toronto, Ontario, M4N3M5, Canada Less <<
NCT01844778 - Completed - -
NCT00834171 - Completed - United States, Virginia ... More >> Maclean, Virginia, United States Less <<
NCT00834171 - Completed - -
NCT00783757 Breast Cancer Not Applicable Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT00794586 Cystic Fibrosis Phase 2 Completed - -
NCT02033486 Breast Cancer Not Applicable Recruiting January 2019 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Principal Investigator: David A Boas, PhD Less <<
NCT00576251 Ocular Inflammation Associated... More >> With Blepharaconjunctivitis Less << Phase 3 Completed - United States, Texas ... More >> Houston Houston, Texas, United States, 77090 Less <<
NCT01082367 Treatment of Early Pulmonary I... More >>nfections With P. Aeruginosa in Cystic Fibrosis Patients Less << Phase 3 Completed - Canada, Ontario ... More >> Novartis Investigative Site Toronto, Ontario, Canada, M5G 1X8 Canada, Quebec Novartis Investigative Site Montreal, Quebec, Canada, H3T1C5 Egypt Novartis Investigative Site Alexandria, Egypt, 21131 France Novartis Investigative Site Bordeaux, France, 33076 Novartis Investigative Site Paris, France, 75019 Germany Novartis Investigative Site Dresden, Germany, 01307 Greece Novartis Investigative Site Thessaloniki, GR, Greece, 546 29 Novartis Investigative Site Thessaloniki, GR, Greece, 546 42 Novartis Investigative Site Patras, Greece, 265 00 Hungary Novartis Investigative Site Debrecen, Hungary, 4032 Novartis Investigative Site Debrecen, Hungary, 4043 Novartis Investigative Site Kaposvar, Hungary, 7400 Novartis Investigative Site Szeged, Hungary, 6725 Italy Novartis Investigative Site Milano, MI, Italy, 20122 Romania Novartis Investigative Site Bucuresti, Romania, 20395 Russian Federation Novartis Investigative Site Kazan, Russian Federation, 420012 Novartis Investigative Site Voronezh, Russian Federation, 394036 Novartis Investigative Site Yaroslavl, Russian Federation, 150003 Switzerland Novartis Investigative Site Zürich, Switzerland, 8032 Less <<
NCT01082367 - Completed - -
NCT01400750 Cystic Fibrosis Phase 4 Completed - Belgium ... More >> Department of pediatrics, CF center Uuiversity Hospital Leuven Leuven, Belgium, 3000 Less <<
NCT02449031 - Active, not recruiting July 31, 2023 -
NCT00006280 Cystic Fibrosis Phase 2 Completed - United States, California ... More >> Stanford University/Lucille Packard Children's Health Services at Stanford Palo Alto, California, United States, 94304 United States, Colorado The Children's Hospital Denver, Colorado, United States, 80218 United States, Maryland Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 United States, Massachusetts Children's Hospital Boston, Massachusetts, United States, 02115 United States, North Carolina University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599 United States, Ohio Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 Rainbow Babies and Children's Hospital Cleveland, Ohio, United States, 44106 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 United States, Washington Children's Hospital and Regional Medical Center Seattle, Washington, United States, 98105 Less <<
NCT00198523 Eye Infections ... More >> Postoperative Complications Less << Phase 3 Completed - United States, Kansas ... More >> Donald E. Beahm, MD Great Bend, Kansas, United States, 67530 United States, Massachusetts Cornea Consultants/Laser Eye Consultants of Boston Boston, Massachusetts, United States, 02114 United States, Michigan Great Lakes Eye Care St. Joseph, Michigan, United States, 49085 United States, New Hampshire Eyesight Ophthalmic Services, PA Portsmouth, New Hampshire, United States, 03801 United States, Texas Texan Eye Care PA Austin, Texas, United States, 78705 Houston Eye Associates Houston, Texas, United States, 77025 Less <<
NCT00576251 - Completed - -
NCT01288170 Cystic Fibrosis Not Applicable Unknown - France ... More >> Centre de ressources et de compétences pour la mucovisidose, enfants Recruiting Bron, France, 69500 Principal Investigator: Gabriel Bellon, Professor          Centre de ressources et de compétences pour la mucovisidose, adultes Not yet recruiting Pierre-Bénite, France, 69495 Sub-Investigator: Isabelle Durieu, Professor Less <<
NCT00705159 Conjunctivitis Phase 4 Completed - United States, Pennsylvania ... More >> Pediatric Ophthalmology of Erie Erie, Pennsylvania, United States, 16501 Less <<
NCT03739528 Cataract Phase 3 Recruiting March 2019 -
NCT01069705 Pulmonary Infections ... More >> Pseudomonas Aeruginosa Less << Phase 3 Completed - Bulgaria ... More >> Novartis Investigative Site Pleven, Bulgaria Novartis Investigative Site Polvdiv, Bulgaria Novartis Investigative Site Sofia, Bulgaria Novartis Investigative Site Varna, Bulgaria Estonia Novartis Investigative Site Tallin, Estonia Novartis Investigative Site Tartu, Estonia Latvia Novartis Investigative Site Riga, Latvia Lithuania Novartis Investigative Site Kaunas, Lithuania Novartis Investigative Site Vilnius, Lithuania Romania Novartis Investigative Site Bucharest, Romania Novartis Investigative Site Timisoara, Romania Russian Federation Novartis Investigative Site Kazan, Russian Federation Novartis Investigative Site Moscow, Russian Federation Novartis Investigative Site Saint Petersburg, Russian Federation Novartis Investigative Site Samara, Russian Federation Novartis Investigative Site Yaroslavl, Russian Federation South Africa Novartis Investigative Site Durban, South Africa Less <<
NCT00982930 Pseudomonas Aeruginosa ... More >> Cystic Fibrosis Less << Phase 3 Completed - Estonia ... More >> Novartis Investigative Site Tallin, Estonia Russian Federation Novartis Investigative Site Yaroslavl, Russian Federation Less <<
NCT02113397 - Terminated(Insufficient enroll... More >>ment) Less << - United States, New Hampshire ... More >> Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 Less <<
NCT01460836 - Completed - -
NCT02712983 Non-cystic Fibrosis Bronchiect... More >>asis Less << Phase 2 Recruiting October 16, 2019 -
NCT00992355 Cataract Not Applicable Completed - Greece ... More >> Department of Ophthalmology, Veroia General Hospital Veroia, Greece, 59100 Less <<
NCT01028027 Conjunctivitis ... More >> Keratitis Blepharitis Less << Phase 3 Completed - Singapore ... More >> Bausch & Lomb Inc Singapore, Singapore, 556741 Less <<
NCT01270347 Cystic Fibrosis Phase 3 Completed - -
NCT00774072 Cystic Fibrosis ... More >> Pseudomonas Aeruginosa Less << Phase 2 Completed - Germany ... More >> Universitäts-Kinderklinik Tübingen, Baden-Würtemberg, Germany, 72076 Mukoviszidosezentrum der Friedrich-Schiller-Universität Jena, Thüringen, Germany, 07745 Less <<
NCT01028027 - Completed - -
NCT01111383 Cystic Fibrosis Phase 3 Completed - France ... More >> CHR Clemenceau Caen, France, 14 033 Hopital Arnaud de Villeneuve, Clinique des maladies respiratoires Montpellier, France, 34 295 Hopital Necker Paris, France, 75 015 Poland Specjalistyczny ZOZ nad Matka i Dzieckiem, Poradnia Leczenia Mukowiscydozy Gdansk, Poland, 80-308 I Oddzial Chorob Dzieciecych, Wojewodzki Specjalistyczny Szpital Dzieciecy Kielce, Poland, 25-381 Oddzial Kliniczny Interny Dzieciecej i Alergologii, Wojewodzki Szpital Specjalistyczny Lodz, Poland, 93-513 Dzieciecy Szpital Kliniczny Akademii Medycznej, Klinika Chorob Pluc I Reumatologii Lublin, Poland, 20-093 Klinika Pneumonologii, Alergologii Dzieciecej i Immunologii Klinicznej Szpital Kliniczny Uniwersytetu Medycznego w Poznaniu Poznan, Poland, 60-572 Klinika Pneumonologii i Mukowiscydozy, Instytut Gruzlicy i Chorob Pluc w Rabce Zdroj Rabka Zdroj, Poland, 34-700 Poradnia Mukowiscydozy Wojewodzkiej, Przychodni Specjalistycznej dla Dzieci, Szpitala Wojewodzkiego Nr 2 Rzeszow, Poland, 35-301 Klinika Pediatrii Instytut Matki I Dziecka Warszawa, Poland, 01-211 Ukraine Dnipropetrovsk City Children Clinical Hospital # 2 Dnipropetrovsk, Ukraine, 49101 Donetsk Regional Children Clinical Hospital Donetsk, Ukraine, 83052 Kriviy Rig City Clinical Hospital # 8 Kriviy Rig, Ukraine, 50047 Institute of Phthysiology and Pulmonology n.a., F.G.Yanovskiy of the Academy of Medical Science of Ukraine Kyiv, Ukraine, 03680 Institute of Pediatrics, Obstetrics and Gynecology of the Academy of Medical Science of Ukraine Kyiv, Ukraine, 04050 Lviv Regional Children Specialized Clinical Hospital Lviv, Ukraine, 79035 Odesa Regional Children Clinical Hospital Odesa, Ukraine, 65031 Simferopol Central District Clinical Hospital Simferopol, Ukraine, 95033 Zaporizhya Regional Clinical Children Hospital Zaporizhya, Ukraine Less <<
NCT00391976 Cystic Fibrosis Phase 3 Completed - -
NCT03502070 Cystic Fibrosis Phase 4 Recruiting June 27, 2019 United States, Oklahoma ... More >> Novartis Investigative Site Recruiting Oklahoma City, Oklahoma, United States, 73112 Less <<
NCT00391976 - Completed - -
NCT00105469 Bacterial Conjunctivitis Phase 3 Completed - -
NCT03066453 Cystic Fibrosis Phase 3 Recruiting February 2021 France ... More >> CRCM pédiatrique - CHU d'Amiens Hôpital Nord Not yet recruiting Amiens, France Principal Investigator: Claire POULET, MD          CRCM mixte - CHU de Caen Hôpital Côte de Nacre Not yet recruiting Caen, France Principal Investigator: Jacques BROUARD, MD,PhD          CRCM mixte - CH de Dunkerque Not yet recruiting Dunkerque, France Principal Investigator: Manuela SCALBERT, MD          CRCM mixte - CH de Lens Not yet recruiting Lens, France Principal Investigator: Sarah MITHA, MD          CRCM adulte - CHRU de Lille Hôpital Calmette Recruiting Lille, France Principal Investigator: Anne Prévotat, MD          CRCM pédiatrique - CHRU de Lille Hôpital Jeanne de Flandres Not yet recruiting Lille, France Principal Investigator: Nathalie WIZLA, MD          CRCM mixte - CHU de Rouen Hôpital Charles Nicolle Not yet recruiting Rouen, France Principal Investigator: Stéphane DOMINIQUE, MD Less <<
NCT01103401 Cataract Not Applicable Completed - -
NCT00257790 Neutropenia F... More >>ever Cancer Less << Phase 4 Completed - -
NCT02178540 Cystic Fibrosis Phase 4 Completed - United States, Arizona ... More >> Novartis Investigative Site Phoenix, Arizona, United States, 85016 United States, California Novartis Investigative Site Long Beach, California, United States, 90806 Novartis Investigative Site Los Angeles, California, United States, 90027 Novartis Investigative Site Ventura, California, United States, 93003 United States, District of Columbia Novartis Investigative Site Washington, District of Columbia, United States, 20010-2120 United States, Florida Novartis Investigative Site Jacksonville, Florida, United States, 32207 United States, Illinois Novartis Investigative Site Chicago, Illinois, United States, 60611 United States, New York Novartis Investigative Site New York, New York, United States, 10595 United States, Ohio Novartis Investigative Site Toledo, Ohio, United States, 43606 United States, Oklahoma Novartis Investigative Site Oklahoma City, Oklahoma, United States, 73104 Novartis Investigative Site Oklahoma City, Oklahoma, United States, 73112 United States, Oregon Novartis Investigative Site Portland, Oregon, United States, 97239 United States, Texas Novartis Investigative Site Houston, Texas, United States, 77030 Less <<
NCT02657473 Non-CF Bronchiectasis Phase 2 Phase 3 Recruiting August 2021 Netherlands ... More >> North West Clinics Recruiting Alkmaar, Noord-Holland, Netherlands, 1815JD Contact: Lotte Terpstra, researcher    0031725184444 ext 5819    l.c.terpstra@nwz.nl Less <<
NCT00705159 - Completed - -
NCT00125346 Cystic Fibrosis Phase 3 Terminated(per Data Monitoring... More >> Committee recommendation) Less << - -
NCT00105469 - Completed - -
NCT00757237 - Completed - -
NCT00757237 Cystic Fibrosis Phase 3 Completed - -
NCT02178540 - Completed - -
NCT01519661 Pulmonary Infections ... More >> Pseudomonas Aeruginosa in Cystic Fibrosis Less << Phase 4 Completed - -
NCT01337219 Cystic Fibrosis PHASE1|PHASE2 UNKNOWN - Centre de Ressource et de Comp... More >>étence Mucoviscidose Pédiatrique Centre de Référence Mucoviscidose, Lyon, 69500, France Less <<
NCT03721328 Prosthetic Joint Infection Phase 2 Recruiting April 2019 United States, Colorado ... More >> Sky Ridge Hospital Not yet recruiting Lone Tree, Colorado, United States, 80124 Contact: Kim Martin, Phd    303-261-7891    kim.martin@boulderclinicalscience.com    United States, Indiana Ortho Indy Not yet recruiting Indianapolis, Indiana, United States, 46278 Contact: Molly Miller    317-802-2851    molmiller@orthoindy.com    Principal Investigator: Edward Helman, MD          United States, Michigan Covenant Hospital Recruiting Saginaw, Michigan, United States, 48604 Contact: Dianne Androsuk    989-583-5173    dianne.androsuk@chs-mi.com    Principal Investigator: Brian de Beaubian, MD          United States, North Carolina Ortho Carolina Research Institute Recruiting Charlotte, North Carolina, United States, 28207 Contact: Amy Roznowski    704-323-2263    amy.roznowski@orthocarolina.com    Contact: Christi Cadd    704-323-2263    Christi.Cadd@orthocarolina.com    Principal Investigator: Bryan Springer, MD          United States, Pennsylvania University of Pittsburgh Not yet recruiting Pittsburgh, Pennsylvania, United States, 15261 Contact: Tina Vita, BSN    412-864-3654    vitatm@upmc.edu    Principal Investigator: Kenneth Urish, MD Less <<
NCT01953367 Cystic Fibrosis Phase 1 Completed - Germany ... More >> Inamed GmbH Gauting, Germany, 82131 Less <<
NCT01519661 - Completed - -
NCT02212587 Cystic Fibrosis ... More >> Burkholderia Cepacia Infection Less << Phase 1 Completed - Canada, Ontario ... More >> St. Michael's Hospital Toronto, Ontario, Canada, M5B 1W8 Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Less <<
NCT03341741 Cystic Fibrosis With Pulmonary... More >> Manifestations Less << Phase 3 Completed - -
NCT00634192 Pseudomonas Infections Phase 3 Completed - Germany ... More >> Novartis Investigator Site Berlin, Germany Novartis Investigator Site Frankfurt, Germany Novartis Investigator site Halle/Saale, Germany Novartis Investigator Site Hamburg, Germany Novartis Investigator Site Hannover, Germany Novartis Investigator Site Heidelberg, Germany Novartis Investigator Site Koeln, Germany Novartis Investigator Site Munich, Germany Less <<
NCT00918957 - Completed - -
NCT00420836 Cystic Fibrosis PHASE1 COMPLETED - -
NCT00885365 Cystic Fibrosis Phase 3 Completed - -
NCT01677403 Bronchiectasis Phase 4 Unknown December 2014 China, Shandong ... More >> Shandong University Recruiting Jinan, Shandong, China, 250100 Less <<
NCT00918957 Cystic Fibrosis Phase 3 Completed - Bulgaria ... More >> Novartis Investigative Site Pleven, Bulgaria Novartis Investigative Site Plovdiv, Bulgaria Novartis Investigative Site Sofia, Bulgaria Novartis Investigative Site Varna, Bulgaria Egypt Novartis Investigative Site Alexandria, Egypt Novartis Investigative Site Giza, Egypt Estonia Novartis Investigative Site Tallin, Estonia Novartis Investigative Site Tartu, Estonia India Novartis Investigative Site Chandigarh, India Novartis Investigative Site Hyderabad, India Novartis Investigative Site New Delhi, India Novartis Investigative Site Vellore, India Latvia Novartis Investigative Site Riga, Latvia Lithuania Novartis Investigative Site Kaunas, Lithuania Novartis Investigative Site Vilnius, Lithuania Romania Novartis Investigative Site Bucuresti, Romania Novartis Investigative Site Timisoara, Romania Russian Federation Novartis Investigative Site Kazan, Russian Federation Novartis Investigative Site Moscow, Russian Federation Novartis Investigative Site Saint Petersburg, Russian Federation Novartis Investigative Site Samara, Russian Federation Novartis Investigative Site Voronezh, Russian Federation Novartis Investigator Site Yaroslavi, Russian Federation South Africa Novartis Investigative Site Durban, South Africa Less <<
NCT02440828 Ventilator Associated Pneumoni... More >>a (VAP) Less << Phase 4 Unknown July 2018 Netherlands ... More >> Erasmus MC Recruiting Rotterdam, Netherlands, 3000CA Contact: Rogier Hoek, MD    +31-10-7034744    r.hoek@erasmusmc.nl    Contact: Menno Van der eerden, MD, PhD    +31-10-7034744    m.vandereerden@erasmusmc.nl    Spain Hospital Clinic Not yet recruiting Barcelona, Spain, 08036 Contact: A Torres, MD PhD Prof    93 227 5779    ATORRES@clinic.ub.es Less <<
NCT02677701 Cystic Fibrosis Phase 4 Recruiting March 31, 2020 -
NCT02015663 Cystic Fibrosis Phase 4 Terminated - United States, Alabama ... More >> Novartis Investigative Site Mobile, Alabama, United States, 36608-1128 United States, California Novartis Investigative Site Los Angeles, California, United States, 90027 Novartis Investigative Site Sacramento, California, United States, 95819 Novartis Investigative Site Ventura, California, United States, 93003 United States, Florida Novartis Investigative Site Altamonte Springs, Florida, United States, 32701 Novartis Investigative Site Jacksonville, Florida, United States, 32207 Novartis Investigative Site Miami, Florida, United States, 33136 Novartis Investigative Site Orlando, Florida, United States, 32806 Novartis Investigative Site Pensacola, Florida, United States, 32504 United States, Illinois Novartis Investigative Site Glenview, Illinois, United States, 60025 United States, Indiana Novartis Investigative Site Indianapolis, Indiana, United States, 46202 United States, Iowa Novartis Investigative Site Iowa City, Iowa, United States, 52242 United States, Missouri Novartis Investigative Site St. Louis, Missouri, United States, 63104 United States, New York Novartis Investigative Site New Hyde Park, New York, United States, 11040 Novartis Investigative Site New York, New York, United States, 10595 United States, Ohio Novartis Investigative Site Akron, Ohio, United States, 44308 United States, Oklahoma Novartis Investigative Site Oklahoma City, Oklahoma, United States, 73112 United States, Oregon Novartis Investigative Site Portland, Oregon, United States, 92772 United States, Pennsylvania Novartis Investigative Site Hershey, Pennsylvania, United States, 17033-8050 United States, Texas Novartis Investigative Site Austin, Texas, United States, 78723 United States, Utah Novartis Investigative Site Salt Lake City, Utah, United States, 84132 Less <<
NCT00399945 Cystic Fibrosis PHASE1 COMPLETED - Stoke on Trent, United Kingdom
NCT02015663 - Terminated - -
NCT00388505 Cystic Fibrosis Phase 3 Completed - -
NCT00388505 - Completed - -
NCT00695435 - Completed - -
NCT00695435 Dry Eye Phase 1 Completed - United States, Texas ... More >> Contact Alcon Call Center For Trial Locations Fort Worth, Texas, United States, 76134 Less <<
NCT01608555 Cystic Fibrosis Phase 4 Completed - Italy ... More >> IRCCS Ospedale Maggiore Policlinico via F. Sforza 35 Milan, Italy, 20122 Less <<
NCT00885365 - Completed - -
NCT02888730 Cystic Fibrosis ... More >> Rhinosinusitis Lung Diseases Less << Phase 3 Recruiting January 2019 France ... More >> Centre Hospitalier Universitaire de Clermont ferrand Not yet recruiting Clermont Ferrand, France, 63003 Contact: Laurent Gilain, MD PhD       lgilain@chu-clermontferrand.fr    Principal Investigator: Laurent Gilain, MD PhD          Sub-Investigator: Andre Labbe, MD PhD          Sub-Investigator: Thierry Mom, MD          Sub-Investigator: Nicolas Saroul, MD          Sub-Investigator: Marie Christine Heraud, MD          Sub-Investigator: Sylvie Montcouquiol, MD          Centre Hospitalier Intercommunal de Créteil Recruiting Creteil, France, 94000 Contact: Sandrine LACOUR, PhD    33 1 57 02 23 98    sandrine.lacour@chicreteil.fr    Principal Investigator: Virginie Escabasse, MD PhD          Sub-Investigator: Andre Coste, MD PhD          Sub-Investigator: Ralph Epaud, MD          Sub-Investigator: Bruno Housset, MD PhD          Sub-Investigator: Laurence Bassinet, MD          Centre Hospitalier Universitaire de la Timone Not yet recruiting Marseille, France, 13385 Contact: Justin Michel, MD       justin.michel@ap-hm.fr    Principal Investigator: Justin Michel, MD          Sub-Investigator: Jean Christophe Dubus, MD PhD          Sub-Investigator: Richard Nicollas, MD          Sub-Investigator: Martine Reynaud Gaubert, MD PhD          Sub-Investigator: Patrick Dessi, MD PhD          Sub-Investigator: Laurent Mely, MD          Sub-Investigator: Nadine Dufeu, MD          Centre Hospitalier Universitaire De Nantes Not yet recruiting Nantes, France, 44093 Contact: Olivier Malard, MD PhD       olivier.malard@chu-nantes.fr    Principal Investigator: Olivier Malard, MD PhD          Sub-Investigator: Alain Haloun, MD          Sub-Investigator: Valérie David, MD          Centre Hosiptalier de Nice Not yet recruiting Nice, France, 06002 Contact: Sylvie Leroy, MD       leroy.s2@chu-nice.fr    Principal Investigator: Sylvie Leroy, MD          Sub-Investigator: Sonanda Bailleux, MD          Sub-Investigator: Laurent Castillo, MD PhD          Sub-Investigator: carole Bailly, MD          Centre Hospitalier Universitaire de Toulouse Not yet recruiting Toulouse, France, 31059 Contact: Josiane Percodani, MD       percodani.j@chu-toulouse.fr    Principal Investigator: Josiane Percodani, MD          Sub-Investigator: Elie Serrano, MD PhD          Sub-Investigator: Marie Noelle Calmels, MD          Sub-Investigator: Marlène Murris, MD          Sub-Investigator: Laurent Tetu, MD          Sub-Investigator: François Bremont, MD          Sub-Investigator: Géraldine Labouret, MD          Sub-Investigator: Marie Mittaine, MD Less <<
NCT01207245 Cystic Fibrosis Phase 4 Completed - United Kingdom ... More >> Nottingham University Hospitals NHS Trust Nottingham, Nottinghamshire, United Kingdom, NG7 2UH Less <<
NCT03715322 Bronchiectasis Adult ... More >> Pseudomonas Infections Less << Phase 3 Not yet recruiting June 2020 China, Guangdong ... More >> The First Affiliated Hospital of Guangzhou Medical University Not yet recruiting Guangzhou, Guangdong, China, 510120 Contact: Nan-shan Zhong, MD    +86-13609003622    nanshan@vip.163.com    Principal Investigator: Wei-jie Guan, PhD          Principal Investigator: Guo-jun Zhang, MD          Sub-Investigator: Yong-hua Gao, PhD          Principal Investigator: Jie-ming Qu, MD          Principal Investigator: Jin-fu Xu, MD          Principal Investigator: Yuan-lin Song, MD          Principal Investigator: Jian-ping Zhao, MD          Principal Investigator: Xiao-nan Tao, MD          Principal Investigator: Zong-an Liang, MD          Principal Investigator: Ping Chen, MD          Principal Investigator: Qi-chang Lin, MD          Principal Investigator: Yi-jiang Huang, MD          Principal Investigator: Xue-dong Liu, MD          Principal Investigator: Xing-xiang Xu, MD          Principal Investigator: Wei Zhang, MD          Principal Investigator: Chang-jun Du, MD          Principal Investigator: Xing-lin Gao, MD Less <<
NCT02035488 Bronchiectasis PHASE1|PHASE2 COMPLETED 2025-12-14 University Medical Center Gron... More >>ingen, Groningen, Netherlands Less <<
NCT03485456 Cystic Fibrosis PHASE1|PHASE2 UNKNOWN 2022-01-01 University Medical Center Gron... More >>ingen, Groningen, Netherlands Less <<
NCT01938417 - Completed - -
NCT02207426 Healthy PHASE1 COMPLETED 2025-09-14 Quotient Clinical, Nottingham,... More >> NG11 6JS, United Kingdom Less <<
NCT02102152 Bronchiectasis With Chronic In... More >>fection With Pseudomonas Aeruginosa Less << UNKNOWN 2025-05-16 Pulmonary Institute, Rabin Med... More >>ical Center, Beilinson Campus, Petach Tikva, 49100, Israel Less <<
NCT03904836 Renal Dialysis|Renal Failure, ... More >>Chronic Less << PHASE1 COMPLETED 2019-12-31 Maisonneuve-Rosemont Hospital,... More >> Montréal, Quebec, H1T 2M4, Canada Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.14mL

0.43mL

0.21mL

10.69mL

2.14mL

1.07mL

21.39mL

4.28mL

2.14mL

References

 

Historical Records

Categories